Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning

References

• Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care 2005;28:78-83
   PubMed Web of Science ®Google Scholar
• Asakura T, Seino H, Nakano R, et al. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657-61
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7
   PubMed Web of Science ®Google Scholar
• Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-7
   PubMed Web of Science ®Google Scholar
• Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
   PubMed Web of Science ®Google Scholar
• Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40
   PubMed Web of Science ®Google Scholar
• Arslanoglu I, Saka N, Bundak R, et al. A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia? J Pediatr Endocrinol Metab 2000;13:313-18
   PubMed Web of Science ®Google Scholar
• Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049-67
   PubMed Web of Science ®Google Scholar
• Houtzagers CM, Berntzen PA, van der Stap H, et al. Efficacy and acceptance of two intensified conventional insulin therapy regimens: a long-term cross-over comparison. Diabet Med 1989;6:416-21
   PubMed Web of Science ®Google Scholar
• Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
   PubMed Web of Science ®Google Scholar
• Stockl K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-46
   PubMed Web of Science ®Google Scholar
• Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25; discussion 0-1
   PubMed Web of Science ®Google Scholar
• Hornquist JO, Wikby A, Andersson PO, et al. Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 1990;10:221-30
   PubMed Web of Science ®Google Scholar
• Piscopo MA, Chiesa G, Bonfanti R, et al. Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Biomed 2003;74(Suppl 1):21-5
   PubMedGoogle Scholar
• Peyrot M, Rubin RR. Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes. Diabetes Technol Ther 2011;13:43-8
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
   PubMed Web of Science ®Google Scholar
• Hemmingsen H, Niemeyer M, Hansen MR, et al. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011;13:1207-11
   Google Scholar
• Wielandt JO, Niemeyer M, Hansen MR, et al. An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen. Expert Opin Drug Deliv 2011;8:1271-6
   PubMed Web of Science ®Google Scholar
• Bailey T, Thurman J, Niemeyer M, et al. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Curr Med Res Opin 2011;27:2043-52
   Google Scholar
• Oyer D, Narendran P, Qvist M, et al. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses Expert Opin Drug Deliv 2011;8:1259-69
   Google Scholar
• Clark PE, Valentine V, Bodie JN, et al. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin 2010;26:1745-53
   PubMed Web of Science ®Google Scholar
• Fischer JS, Edelman SV, Schwartz SL. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol 2008;2:1157-60
   PubMedGoogle Scholar
• Brod M, Kongso JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
   PubMed Web of Science ®Google Scholar